Paroxetine

1
Last update : 20/01/2012
I - Interstitial/parenchymal lung disease
II - Pulmonary edema - Acute lung injury - ARDS
IV - Airway involvement
VI - Pulmonary vasculopathies
VIII - Central-large-upper airway (incl. pharyngeal-nasal) involvement
XII - Cardiovascular involvement / toxicity
XV - Pathology

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies